Adiumentum Capital Fund I LP - Director, 10%+ Owner at Atara Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Stock Symbol
ATRA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Adiumentum Capital Fund I LP since 12/17/2023

Holdings reported by Adiumentum Capital Fund I LP for Atara Biotherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, par value $0.0001 per share 1.13M $7.52M $6.63 Sep 3, 2024 Direct

There are no transactions reported by Adiumentum Capital Fund I LP for Atara Biotherapeutics, Inc.